Faheem Hasnain
Net Worth
Last updated:
What is Faheem Hasnain net worth?
The estimated net worth of Mr. Faheem Hasnain is at least $14,796,041 as of 21 Jun 2024. He owns shares worth $10,383,500 as insider, has earned $196,461 from insider trading and has received compensation worth at least $4,216,080 in Gossamer Bio, Inc..
What is the salary of Faheem Hasnain?
Mr. Faheem Hasnain salary is $702,680 per year as Co-Founder, Chief Executive Officer, Pres & Chairman in Gossamer Bio, Inc..
How old is Faheem Hasnain?
Mr. Faheem Hasnain is 67 years old, born in 1958.
What stocks does Faheem Hasnain currently own?
As insider, Mr. Faheem Hasnain owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | Co-Founder, Chief Executive Officer, Pres & Chairman | 5,408,073 | $1.92 | $10,383,500 |
What does Gossamer Bio, Inc. do?
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Faheem Hasnain insider trading
Gossamer Bio, Inc.
Mr. Faheem Hasnain has made 2 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he purchased 372,000 units of GOSS stock worth $250,356 on 21 Jun 2024.
The largest trade he's ever made was exercising 440,500 units of GOSS stock on 22 Mar 2023. As of 21 Jun 2024 he still owns at least 5,408,073 units of GOSS stock.
Gossamer Bio key executives
Gossamer Bio, Inc. executives and other stock owners filed with the SEC:
- Mr. Bryan Giraudo (49) Chief Operating Officer & Chief Financial Officer
- Mr. Christian Waage (58) Executive Vice President, Gen. Counsel & Sec.
- Mr. Faheem Hasnain (67) Co-Founder, Chief Executive Officer, Pres & Chairman